Cambridge biotech Moderna Inc. will submit its first-ever application for drug approval today after new trial data shows its Covid-19 vaccine is 94% effective at preventing the virus.
Moderna (Nasdaq: MRNA) identified 196 cases of Covid among the 30,… […]
The day started unremarkably enough. Sarmed Anwar, who had immigrated to the United States with his family, went to his science class at Berkeley High School as usual. But instead of covering the typical course material that day, a group of people came… […]
Study published in Annals of Oncology validates Signatera(TM) for use in neoadjuvant treatment response monitoring
SAN CARLOS, Calif., Nov. 30, 2020 /PRNewswire/ — Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, to… […]
SAN FRANCISCO, Nov. 30, 2020 /PRNewswire/ — MapLight Therapeutics today announced a $8.1 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to undertake a large-scale, systematic investigation of the brain circuits an… […]
Kinaset Therapeutics is joining the search for a better severe asthma treatment, picking up where Vectura left off when it decided to clear house last year.
UK-based Vectura — which took a big hit when its most advanced candidate flopped in a Phase III… […]